Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 7,175 shares at $32.12 ($230K) on 2026-02-03, disclosed to the SEC on 2026-02-03.
Seasonal sale ($230k) by Chief Legal Officer and GC — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |